Partial Breast Irradiation for High Molecular Risk Early-Stage Breast Cancer
International Journal of Radiation Oncology*Biology*Physics · 2025
DOI: 10.1016/j.ijrobp.2025.04.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Alexander R Terry und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 17 Literaturangaben. Gefördert von: National Institutes of Health, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
PURPOSE: Partial breast irradiation (PBI) is a suitable and well-tolerated alternative to whole breast irradiation (WBI) following lumpectomy for many forms of low-risk, early-stage breast cancer. Molecular risk scores, such as the Oncotype DX recurrence score (ODX RS), are increasingly guiding systemic treatment decisions. However, molecular/genomic profiling for radiation therapy (RT) decision-making remains investigational, and it is unclear whether a high ODX RS should preclude the use of PBI. We compared oncologic outcomes among patients with high ODX RS (>25) treated with PBI versus WBI. METHODS AND MATERIALS: Patients who underwent breast conservation followed by PBI or WBI with ODX RS > 25 were ascertained from a prospectively maintained institutional database. Comparable PBI and WBI cohorts were generated in 1:5 fashion using propensity score matching based on salient clinicopathologic features. We evaluated the incidence of local recurrence (LR) as a function of RT approach. RESULTS: We identified 968 patients with an ODX RS > 25 who were treated with adjuvant RT, with a median age of 59 years (range, 25-86) and a median 5.3 years of follow-up. In a propensity matched cohort analysis that included 28 patients who received PBI matched to 140 who received WBI, we observed 3 LR events among those receiving PBI (2 of which were in different quadrants from the primary lesion) and 5 events among those receiving WBI. Among this cohort with ODX RS > 25, the 72-month cumulative incidence of LR following PBI was 7.9% (95% CI, 1.3%-23%) compared to 4.8% (95% CI, 1.6%-11%) following WBI (P = .6). CONCLUSIONS: In this cohort of patients with high ODX RS, few LRs were observed, and no statistically significant difference in LR was identified between PBI and WBI. Although these findings suggest that PBI may be considered in carefully-selected high-genomic-risk patients, larger studies with longer follow-up are needed to definitively establish the safety of this approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: braunstl@mskcc.org.
Förderung
- National Institutes of Health
- National Institutes of Health National Cancer Institute
Zitieren
APA
Terry, A. R., Boe, L., Pawloski, K. R., O'Brien, D. R., Mueller, B., Choi, J. I., Powell, S., Khan, A. J., Kirstein, L., & Braunstein, L. Z. (2025). Partial Breast Irradiation for High Molecular Risk Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.04.044
Vancouver
Terry AR, Boe L, Pawloski KR, O'Brien DR, Mueller B, Choi JI, et al. Partial Breast Irradiation for High Molecular Risk Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.04.044
BibTeX
@article{Terry2025,
author = {Terry, Alexander R and Boe, Lillian and Pawloski, Kate R and O'Brien, Diana Roth and Mueller, Boris and Choi, J Isabelle and Powell, Simon and Khan, Atif J and Kirstein, Laurie and Braunstein, Lior Z},
title = {Partial Breast Irradiation for High Molecular Risk Early-Stage Breast Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
doi = {10.1016/j.ijrobp.2025.04.044}
}
EUVIMED